Ira Duarte
Vermogen: 681 105 $ op 31-05-2026
Vermogen: 681 105 $ op 31-05-2026
Ira Duarte is currently an Independent Director at Terrascend Corp.
since 2022 and EVP, Chief Financial & Accounting Officer at Heron Therapeutics, Inc. starting in 2024.
Former positions include Chief Financial Officer & VP-Controller at Veloxis Pharmaceuticals A from 2018 to 2023, Controller at BioDelivery Sciences International, Inc. from 2014 to 2016, Director-Accounting & Financial Planning at Chiesi USA, Inc. from 2009 to 2013, and Senior Manager at Ernst & Young A. Education includes undergraduate studies at Florida Atlantic University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
TERRASCEND CORP. 0,21% | 30-06-2026 | 657.930 ( 0,21% ) | 453 972 $ | 31-05-2026 |
| 16-06-2026 | 261.073 ( 0,14% ) | 227 134 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| TERRASCEND CORP. | Directeur/Bestuurslid | 02-12-2022 |
| HERON THERAPEUTICS, INC. | Financieel Directeur/CFO | 16-06-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Financieel Directeur/CFO | 01-01-2023 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Comptroller/Controller/Auditor | 01-01-2016 |
| CORNERSTONE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01-10-2013 |
Ernst & Young A/S
Ernst & Young A/S Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 7 |
|---|---|
Heron Therapeutics, Inc.
Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients | Health Technology |
Florida Atlantic University
Florida Atlantic University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernst & Young A/S
Ernst & Young A/S Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Cornerstone Therapeutics, Inc.
Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for hospital and specialty care areas including respiratory, rare diseases & critical care | Health Technology |
Terrascend Corp.
Terrascend Corp. Agricultural Commodities/MillingProcess Industries Produces and sells medical cannabis products | Process Industries |
Kies jouw editie
Alle financiële informatie op nationaal niveau